Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications
Real World Outcomes of Pembrolizumab and Reduced-Dose Lenvatinib in Recurrent Endometrial Cancer by Platinum and p53 Status.
Journal: Gynecologic oncology reports
Published: November 06, 2025
The multidisciplinary management of a patient with infected iliocaval stents and uterine cancer invasion.
Journal: Journal of vascular surgery cases and innovative techniques
Published: October 17, 2025
Association of platinum-based chemotherapy with survival in ovarian carcinosarcoma: a retrospective 2-center cohort study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 22, 2025
Adverse events beyond the RUBY trial: reporting immunotherapy-associated myocarditis, myositis, and myasthenia gravis in a real-world endometrial cancer case.
Journal: Gynecologic oncology reports
Published: July 28, 2025
Efficacy of Laparoscopic-Assisted Transversus Abdominus Plane (LA-TAP) Block for Minimally Invasive Gynecologic Surgeries (MIGS): A Randomized Controlled Trial.
Journal: Journal of minimally invasive gynecology
Published: July 09, 2025
Fertility preserving, uterine sparing approach to a uterine extragonadal yolk sac tumor.
Journal: Gynecologic oncology reports
Published: April 15, 2025
Vascular segmental exclusion for recurrent vulvar squamous cell carcinoma invading the femoral vessels.
Journal: Journal of vascular surgery cases and innovative techniques
Published: October 28, 2024
Time for Educational Revamp? A Nationwide Survey of Fellowships in Minimally Invasive Gynecologic Surgery Program Directors' and Fellows' Didactic Experiences.
Journal: Journal of minimally invasive gynecology
Published: April 23, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 16, 2024
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Journal: British journal of cancer
Published: March 04, 2024
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2.
Journal: Clinical & experimental metastasis
Published: February 09, 2024
Last Updated: 09/26/2026